Literature DB >> 32425479

MRI Evaluation of the Olfactory Clefts in Patients with SARS-CoV-2 Infection Revealed an Unexpected Mechanism for Olfactory Function Loss.

Michael Eliezer1, Charlotte Hautefort2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32425479      PMCID: PMC7229929          DOI: 10.1016/j.acra.2020.05.013

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


× No keyword cloud information.
Dear Editor, We read with great interest the recent letter by Galougahi et al., which described a patient presenting with isolated anosmia secondary to SARS-CoV-2 infection that was confirmed by the polymerase chain reaction (1). There is now strong evidence that olfactory function loss might be observed in patients with SARS-CoV-2 infection, and in some cases, might even constitute the main symptom (2,3). Galougahi et al. provide the second magnetic resonance imaging (MRI) report of the olfactory bulbs in a patient infected by SARS-CoV-2 presenting with a sudden onset of olfactory function loss without nasal obstruction (1). They found normal olfactory bulbs and tracts with no sign of nasal congestion. However, we were confused by their interpretation of the MRI since a bilateral obstruction of the olfactory clefts, below the olfactory bulbs, is observed, as has been described in our first report (3). The olfactory clefts are two narrow vertical passages at the upper part of the nasal cavities and constitute a crucial pathway for airborne odorant molecules to the olfactory mucosa (4). Biopsies of the olfactory clefts revealed the presence of an olfactory epithelium, which contains the olfactory sensory neurons that express odor receptors (5). Then, the axons of the olfactory sensory neurons cross the cribriform plate to terminate into the olfactory bulbs (5). The pathophysiology of olfactory function loss in patients with SARS-Cov-2 infection remains unclear. Recently, it has been demonstrated that ACE2 proteins, which are targeted by SARS-CoV-2, are express in the olfactory epithelium and not in the olfactory sensory neurons, suggesting the olfactory epithelium as the putative entry site of SARS-CoV-2 (6). Based on their neurotropic potential, coronaviruses could also invade the olfactory axons through the cribriform plate, leading to structural damages to the olfactory sensory neurons (7). We believe that the most plausible explanation for this inflammatory obstruction of the olfactory cleft might be the result of the interaction between SARS-CoV2 and ACE2 protein expressed by the olfactory epithelium. This finding could probably explain the short time to recovery exhibited by most patients (8). We also found, at this stage of the disease, no morphological anomalies of the olfactory bulbs. Yet, they might be slightly impaired and too subtle to be detected on MRI, thus we cannot exclude totally this hypothesis. Further prospective studies with follow-up are warranted to assess the central olfactory pathways in patients with SARS-CoV-2 infection presenting with olfactory function loss.
  7 in total

1.  Biopsies of human olfactory epithelium.

Authors:  Bruce W Jafek; B Murrow; R Michaels; D Restrepo; M Linschoten
Journal:  Chem Senses       Date:  2002-09       Impact factor: 3.160

2.  Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19.

Authors:  Michael Eliezer; Charlotte Hautefort; Anne-Laure Hamel; Benjamin Verillaud; Philippe Herman; Emmanuel Houdart; Corinne Eloit
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-07-01       Impact factor: 6.223

3.  Inflammatory obstruction of the olfactory clefts and olfactory loss in humans: a new syndrome?

Authors:  Didier Trotier; Jean Loup Bensimon; Philippe Herman; Patrice Tran Ba Huy; Kjell B Døving; Corinne Eloit
Journal:  Chem Senses       Date:  2007-01-20       Impact factor: 3.160

4.  Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?

Authors:  S B Gane; C Kelly; C Hopkins
Journal:  Rhinology       Date:  2020-06-01       Impact factor: 3.681

5.  Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study.

Authors:  Claire Hopkins; Pavol Surda; Emily Whitehead; B Nirmal Kumar
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-05-04

Review 6.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

7.  Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report.

Authors:  Mahboobeh Karimi Galougahi; Jahangir Ghorbani; Mehrdad Bakhshayeshkaram; Ali Safavi Naeini; Sara Haseli
Journal:  Acad Radiol       Date:  2020-04-11       Impact factor: 3.173

  7 in total
  8 in total

Review 1.  Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.

Authors:  Richard L Doty
Journal:  Trends Mol Med       Date:  2022-06-20       Impact factor: 15.272

2.  Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population.

Authors:  Behzad Iravani; Artin Arshamian; Aharon Ravia; Eva Mishor; Kobi Snitz; Sagit Shushan; Yehudah Roth; Ofer Perl; Danielle Honigstein; Reut Weissgross; Shiri Karagach; Gernot Ernst; Masako Okamoto; Zachary Mainen; Erminio Monteleone; Caterina Dinnella; Sara Spinelli; Franklin Mariño-Sánchez; Camille Ferdenzi; Monique Smeets; Kazushige Touhara; Moustafa Bensafi; Thomas Hummel; Noam Sobel; Johan N Lundström
Journal:  Chem Senses       Date:  2020-05-22       Impact factor: 3.160

3.  Reply to "MRI Evaluation of the Olfactory Clefts in Patients with SARS-CoV-2 Infection Revealed an Unexpected Mechanism for Olfactory Function Loss".

Authors:  Sara Haseli; Mahboobeh Karimi-Galougahi
Journal:  Acad Radiol       Date:  2020-06-10       Impact factor: 3.173

4.  Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia.

Authors:  Sedat Giray Kandemirli; Aytug Altundag; Duzgun Yildirim; Deniz Esin Tekcan Sanli; Ozlem Saatci
Journal:  Acad Radiol       Date:  2020-10-19       Impact factor: 3.173

5.  Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients.

Authors:  Luigi Angelo Vaira; Jerome R Lechien; Mohamad Khalife; Marzia Petrocelli; Stephane Hans; Lea Distinguin; Giovanni Salzano; Marco Cucurullo; Piero Doneddu; Francesco Antonio Salzano; Federico Biglioli; Fabrice Journe; Andrea Fausto Piana; Giacomo De Riu; Sven Saussez
Journal:  Pathogens       Date:  2021-01-12

6.  Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.

Authors:  Serge-Daniel Le Bon; Deborah Konopnicki; Nathalie Pisarski; Léa Prunier; Jérôme R Lechien; Mihaela Horoi
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-09       Impact factor: 2.503

Review 7.  COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review.

Authors:  Jasjit S Suri; Anudeep Puvvula; Mainak Biswas; Misha Majhail; Luca Saba; Gavino Faa; Inder M Singh; Ronald Oberleitner; Monika Turk; Paramjit S Chadha; Amer M Johri; J Miguel Sanches; Narendra N Khanna; Klaudija Viskovic; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; David W Sobel; Antonella Balestrieri; Petros P Sfikakis; George Tsoulfas; Athanasios Protogerou; Durga Prasanna Misra; Vikas Agarwal; George D Kitas; Puneet Ahluwalia; Raghu Kolluri; Jagjit Teji; Mustafa Al Maini; Ann Agbakoba; Surinder K Dhanjil; Meyypan Sockalingam; Ajit Saxena; Andrew Nicolaides; Aditya Sharma; Vijay Rathore; Janet N A Ajuluchukwu; Mostafa Fatemi; Azra Alizad; Vijay Viswanathan; Pudukode R Krishnan; Subbaram Naidu
Journal:  Comput Biol Med       Date:  2020-08-14       Impact factor: 4.589

8.  Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.

Authors:  L A Vaira; C Hopkins; A Sandison; A Manca; N Machouchas; D Turilli; J R Lechien; M R Barillari; G Salzano; A Cossu; S Saussez; G De Riu
Journal:  J Laryngol Otol       Date:  2020-11-16       Impact factor: 1.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.